Experiment 1084952

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEINFRARED SPECTRUM REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDX-RAY CHRYSTALLOGRAPHIC STUDIESCOMPLETE SYNTHESIS REPORTEDUV SPECTRUM GIVEN FORSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEPMR SPECTRUM REPORTED

Compounds isolated

CYCLOALKANNIN LEUCOACETATE

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismEmpty organism
CitationSANKAWA,U: OTSUKA,H: KATAOKA,H: IITAKA,Y: HOSHI,A: KURETANI,K:. (1981). ANTITUMOR ACTIVITY OF SHIKONIN,ALKANNIN AND THEIR DERIVATIVES. II.X-RAY ANALYSIS OF CYCLO-ALKANNIN LEUCOACETATE, TAUTOMERISM OF ALKANNIN AND CYCLO-ALKANNIN AND ANTITUMOR ACTIVITY OF ALKANNIN DERIVATIVES.. 29()
Amount utilized
Compound isolated
Dose amount12.5 MG
Number1
Qualitative resultINACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE